Soybean Peptide Lunasin Suppresses In Vitro and In Vivo 7,12-Dimethylbenz[a]anthracene-Induced Tumorigenesis

Chia Chien Hsieh, Blanca Hernández-Ledesma, Ben O. De Lumen

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Abstract: Lunasin is a novel peptide identified in soybean and other seeds. This study evaluated the anti-tumorigenic effects of lunasin on 7,12-dimethylbenz(a)anthracene (DMBA) and 3-methylcholanthrene-treated (MCA) fibroblast NIH/3T3 cells. Lunasin significantly inhibited cell proliferation and cancerous foci formation in these 2 chemical carcinogens-treated cells. An in vivo SENCAR mouse model induced with DMBA was used to study the mammary cancer preventive properties of dietary lunasin contained in soy protein. Tumor incidence was 67% and 50%, and the tumor generation was 1.88 ± 0.48 and 1.17 ± 0.17, respectively, for the mice fed control diet and experimental diet obtained after AIN-93G supplementation with lunasin-enriched soy protein concentrate (containing 0.23% lunasin). However, no effects were observed in mice fed AIN-93G supplemented with soy protein concentrate (containing 0.15% lunasin). The data provided illustrate the anticancer potential of lunasin both in vitro and in vivo and supports the recommendation of soy protein as a dietary component that may aid in the prevention of mammary cancer.Practical Application: Daily intake of lunasin-enriched soy protein is introduced as a promising strategy to prevent chemical carcinogens-induced mammary tumors.

Original languageEnglish
Pages (from-to)H311-H316
JournalJournal of Food Science
Volume75
Issue number9
DOIs
Publication statusPublished - 2010 Nov 1
Externally publishedYes

    Fingerprint

Keywords

  • 12-dimethylbenz(a)anthracene
  • 3-methylcholanthrene
  • 7
  • Cancer preventive properties
  • Lunasin
  • Mammary cancer
  • Soy protein

ASJC Scopus subject areas

  • Food Science

Cite this